Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40007032
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
04/04/2024
Statut
Classification
1.5°C
Année cible
2030
Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* Johnson & Johnson also commits that 80% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2028. * The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.
Statut
Commitment removedStatut
BA1.5 memberDate d'engagement
27/05/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US4781601046
LEI
549300G0CFPGEF6X2043
Expired commitment
Source : Science Based Targets initiative | Données publiques